InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Mutuum Finance (MUTM) Completes Smart Contracts in Preparation for Q4 2025 Testing
Dubai, UAE, Dec. 14, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…
Free Spins No Deposit Casino | Real Money Online Casino No Deposit Bonus By Cafe Casino
New York City, NY, Dec. 13, 2025 (GLOBE NEWSWIRE) -- . Free…
1st Detect’s Aviation Security Technology Ready to Support the U.S. Aviation Security Modernization Initiative
1st Detect Corporation's detection and analysis mass spectrometry systems deployed worldwide offer…
Extendicare Announces December 2025 Dividend of C$0.042 per Share
December 12, 2025 17:00 ET | Source: Extendicare Inc. MARKHAM, Ontario, Dec.…
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025 16:30 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec.…
Teva Releases Q4 2025 Aide Memoire
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
New Crypto Coin Mutuum Finance (MUTM) Nears 100% of Phase 6 Allocation as Investor Activity Accelerates
Dubai, UAE, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a…
Fobi AI Announces Partial Revocation Order and Non-Brokered Private Placement
Not for distribution to U.S. news wire services or dissemination in the…
